The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia

Sasmaz I., Tanyeli A., Bayram I., Antmen B., Yilmaz L., Kucukosmanoglu O., ...Daha Fazla

TURKISH JOURNAL OF PEDIATRICS, cilt.46, sa.1, ss.32-37, 2004 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 1
  • Basım Tarihi: 2004
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.32-37
  • Çukurova Üniversitesi Adresli: Evet

Özet

Anthracycline and cytosine arabinoside are used in combination as the standard therapy for remission induction of acute nonlymphoblastic leukemia. Idarubicin, a synthetic daunorubicin analogue, shows an improved spectrum activity and diminishes acute or chronic toxicity when compared with the other anthracyclines. This study has been carried out in our clinic in order to evaluate the efficiency of the acute nonlymphoblastic leukemia protocol which includes idarubicin.